Timolol Maleate Ophthalmic Solution USP, 0.5%, packaged in: a) 5mL bottle (NDC 64980-514-05), and...
FDA Drug Recall #D-0642-2024 — Class II — August 12, 2024
Recall Summary
| Recall Number | D-0642-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 12, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | FDC Limited |
| Location | Aurangabad, Maharashtra State |
| Product Type | Drugs |
| Quantity | 176,784 bottles |
Product Description
Timolol Maleate Ophthalmic Solution USP, 0.5%, packaged in: a) 5mL bottle (NDC 64980-514-05), and b) 10mL bottle (NDC 64980-514-01), Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey
Reason for Recall
Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Distribution Pattern
Nationwide U.S.A.
Lot / Code Information
Lot #: a) 083K063, Exp 10/31/2025; b) 083I091, Exp 08/31/2025.
Other Recalls from FDC Limited
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0543-2025 | Class II | Timolol Maleate Ophthalmic Solution USP, 0.5%, ... | Jul 5, 2025 |
| D-0403-2025 | Class II | Timolol Maleate Ophthalmic Solution USP, 0.5%, ... | Apr 18, 2025 |
| D-0282-2025 | Class II | Ciprofloxacin Ophthalmic Solution USP, 0.3% as ... | Mar 11, 2025 |
| D-0214-2025 | Class II | Timolol Maleate Ophthalmic Solution USP, 0.5%, ... | Jan 23, 2025 |
| D-0182-2025 | Class II | Ciprofloxacin Ophthalmic Solution USP, 0.3% as ... | Dec 16, 2024 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.